Target type: biologicalprocess
The series of events in which a cold stimulus is received and converted into a molecular signal as part of thermoception. [PMID:21335241]
Cold sensation, or thermoception, is a complex process involving specialized sensory neurons called cold receptors that are located in the skin and other tissues. These receptors are activated by a decrease in temperature, triggering a cascade of events that ultimately lead to the perception of cold.
The process begins with the activation of cold receptors, which are typically transient receptor potential (TRP) ion channels, specifically TRPM8 and TRPA1. These ion channels are sensitive to temperature changes and open when the temperature drops below a certain threshold.
Once the TRP channels open, they allow the influx of sodium and calcium ions into the sensory neuron, causing the cell to depolarize. This depolarization triggers the generation of action potentials, electrical signals that travel along the neuron's axon to the spinal cord.
In the spinal cord, these action potentials synapse with other neurons, sending the signal to the thalamus, a relay center in the brain. From the thalamus, the signal is relayed to the somatosensory cortex, the area of the brain responsible for processing sensory information, including temperature.
The somatosensory cortex interprets the signal, leading to the conscious perception of cold. This perception is influenced by various factors, including the intensity and duration of the cold stimulus, the temperature of the surrounding environment, and the individual's sensitivity to cold.
In addition to the direct activation of cold receptors, the perception of cold can also be influenced by other mechanisms. For example, the release of neurotransmitters like substance P and glutamate can modulate the activity of cold receptors and influence the intensity of the cold sensation.
The body's response to cold stimuli is crucial for maintaining core body temperature and preventing hypothermia. The sensation of cold serves as a warning system, prompting individuals to seek warmth and avoid prolonged exposure to cold temperatures.
Furthermore, the perception of cold plays a role in various physiological processes, including the regulation of blood flow, metabolism, and the immune system.'
"
Protein | Definition | Taxonomy |
---|---|---|
Glutamate receptor ionotropic, kainate 2 | A glutamate receptor ionotropic, kainate 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q13002] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. | non-proteinogenic alpha-amino acid | |
kainic acid | Kainic Acid: (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose. | dicarboxylic acid; L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid | antinematodal drug; excitatory amino acid agonist |
glutamic acid | glutamic acid : An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2. Glutamic Acid: A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
sym 2081 | |||
ly 293558 | tezampanel: structure given in first source; an AMPA receptor antagonist | ||
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | |||
ly382884 | benzoic acids | ||
4-bromohomoibotenic acid, (rs)-isomer | |||
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline | 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline: structure given in first source; neuroprotectant for cerebral ischemia; AMPA receptor antagonist | naphthalenes; sulfonic acid derivative | |
ubp 310 | UBP 310: a GluR5 antagonist; structure in first source | ||
ubp 302 | |||
dysiherbaine | dysiherbaine : A furopyran that is (3aR,7aR)-hexahydro-2H-furo[3,2-b]pyran substituted by carboxy, (2S)-2-amino-2-carboxyethyl, hydroxy and methylamino groups at positions 2, 2, 6, and 7, respectively (the 2R,3aR,6S,7R,7aR-stereoisomer). A convulsant isolated from the marine sponge Dysidea herbacea that has high affinity for kainate ionotropic glutamate receptors. dysiherbaine: an exitotoxic amino acid; structure in first source | amino dicarboxylic acid; furopyran; hydroxy carboxylic acid; secondary amino compound | animal metabolite; excitatory amino acid agonist; marine metabolite; neurotoxin |